NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 140 filers reported holding NOVAVAX INC in Q2 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $70,000 | -56.8% | 52,073 | -32.3% | 0.00% | -100.0% |
| Q1 2018 | $162,000 | -50.0% | 76,921 | +72.5% | 0.00% | -50.0% |
| Q2 2016 | $324,000 | +49.3% | 44,604 | +5.7% | 0.00% | +100.0% |
| Q1 2016 | $217,000 | -38.5% | 42,192 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $353,000 | +390.3% | 42,192 | +165.0% | 0.00% | – |
| Q1 2014 | $72,000 | -11.1% | 15,919 | 0.0% | 0.00% | – |
| Q4 2013 | $81,000 | +125.0% | 15,919 | +37.0% | 0.00% | – |
| Q3 2013 | $36,000 | +56.5% | 11,618 | +2.9% | 0.00% | – |
| Q2 2013 | $23,000 | – | 11,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |